Who are Anti Thymocyte Globulin's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): HUMAN IMMUNOGLOBULIN G, Human immunoglobulin, Botulinum neurotoxin.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/anti-thymocyte-globulin.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Anti Thymocyte Globulin — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anti Thymocyte Globulin (Anti Thymocyte Globulin) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Immunoglobulin G [EPC].

marketed Immunoglobulin G [EPC] Small molecule Live · refreshed every 30 min

Target snapshot

Anti Thymocyte Globulin (Anti Thymocyte Globulin) — Novartis Pharmaceuticals.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Approval / PDUFA
Anti Thymocyte Globulin TARGET	Anti Thymocyte Globulin	Novartis Pharmaceuticals	marketed	Immunoglobulin G [EPC]
HUMAN IMMUNOGLOBULIN G	HUMAN IMMUNOGLOBULIN G		marketed	Human Immunoglobulin G [EPC]	2006-01-01
Human immunoglobulin	Human immunoglobulin	Centre Hospitalier St Anne	marketed	Human Immunoglobulin G [EPC]
Botulinum neurotoxin	Botulinum neurotoxin	University of Miami	marketed	Human Immunoglobulin G [EPC]

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Immunoglobulin G [EPC] class)

Novartis Pharmaceuticals · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Anti Thymocyte Globulin — Competitive Intelligence Brief. https://druglandscape.com/ci/anti-thymocyte-globulin. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab